Some people lose far more weight than others on GLP-1s like Wegovy. Here’s why.

Research reveals that some individuals, referred to as 'super-responders', experience significant weight loss when taking GLP-1 drugs like Wegovy, while others do not respond at all. This variation in response is a key finding in emerging research on GLP-1 medications. The difference in response rates among patients may lead to more personalized treatment approaches.